Dashboard
Manage Tickers

BMYBRISTOL MYERS SQUIBB CO

NYSE bms.com


$ 44.22 $ 0.27 (0.61 %)    

Wednesday, 01-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 44.21
$ 43.94
$ 0.00 x 0
$ 0.00 x 0
$ 43.74 - $ 44.42
$ 43.73 - $ 66.25
13,241,523
na
89.62B
$ 0.54
nm
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-13-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-14-2023 12-31-2022 10-K
7 10-26-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-10-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-25-2019 06-30-2019 10-Q
21 04-25-2019 03-31-2019 10-Q
22 02-25-2019 12-31-2018 10-K
23 10-25-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 04-26-2018 03-31-2018 10-Q
26 02-13-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-27-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-28-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 10-27-2015 09-30-2015 10-Q
36 07-23-2015 06-30-2015 10-Q
37 04-28-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 10-24-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Editas Medicine Announced A Two-year Exten...
05/01/2024 12:09:34

Under the collaboration, Bristol Myers Squibb has opted into 13 different programs across 11 gene targets to date. Two programs...

a-closer-look-at-bristol-myers-squibbs-options-market-dynamics
A Closer Look at Bristol-Myers Squibb's Op...
04/30/2024 15:31:12

scenic-biotech-enters-into-research-collaboration-with-bristol-myers-squibb
Scenic Biotech Enters Into Research Collab...
04/30/2024 09:03:24

Bristol Myers Squibb gains access to Scenic's Cell-Seq technology platform to unlock the underlying genetic interactions of...

how-is-the-market-feeling-about-bristol-myers-squibb
How Is The Market Feeling About Bristol-My...
04/29/2024 15:45:26

bristol-myers-squibb-and-repertoire-announce-18b-deal-to-reset-immune-system-in-autoimmune-patients
Bristol Myers Squibb and Repertoire Announ...
04/29/2024 10:03:18

Repertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted ...

will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week
Will Earnings Cheer Continue To Buoy Marke...
04/29/2024 05:51:21

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

last-weeks-worst-performing-stocks-are-these-10-large-cap-stocks-in-your-portfolio-april-21-27-2024
Last Week's Worst-Performing Stocks: Are T...
04/28/2024 22:27:40

10 worst performing large-cap stocks last week: LKQ, MSCI, TXT, EDU, BMY, MANH, RS, META, LUV, NUE. Analysts cut price targets ...

bmo-capital-maintains-market-perform-on-bristol-myers-squibb-lowers-price-target-to-48
BMO Capital Maintains Market Perform on Br...
04/26/2024 18:10:34

BMO Capital analyst Evan Seigerman maintains Bristol-Myers Squibb (NYSE:BMY) with a Market Perform and lowers the price targ...

peeling-back-the-layers-exploring-bristol-myers-squibb-through-analyst-insights
Peeling Back The Layers: Exploring Bristol...
04/26/2024 17:00:24

barclays-maintains-equal-weight-on-bristol-myers-squibb-lowers-price-target-to-43
Barclays Maintains Equal-Weight on Bristol...
04/26/2024 13:33:06

Barclays analyst Carter Gould maintains Bristol-Myers Squibb (NYSE:BMY) with a Equal-Weight and lowers the price target from...

bristol-myers-says-emas-chmp-recommended-approval-of-opdivo-combination-with-cisplatin-gemcitabine-for-first-line-treatment-of-adult-patients-with-unresectable-or-metastatic-urothelial-carcinoma
Bristol Myers Says EMA's CHMP Recommended ...
04/26/2024 11:04:49

The European Commission (EC), which has the authority to approve medicines for the European Union (EU), will now review the CHM...

investor-sentiment-improves-slightly-but-dow-tumbles-over-350-points
Investor Sentiment Improves Slightly, But ...
04/26/2024 06:59:07

crude-oil-moves-higher-bristol-myers-squibb-shares-fall-after-q1-results
Crude Oil Moves Higher; Bristol Myers Squi...
04/25/2024 18:32:33

why-caterpillar-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Caterpillar Shares Are Trading Lower B...
04/25/2024 17:57:17

bristol-myers-squibb-swings-to-quarterly-loss-after-string-of-multi-billion-acquisitions
Bristol Myers Squibb Swings To Quarterly L...
04/25/2024 16:23:39

Discover Bristol Myers Squibb's impressive first-quarter performance, with revenues exceeding expectations driven by key pr...

bristol-myers-squibb-revises-2024-adjusted-eps-guidance-from-710-740-to-040-070-versus-consensus-of-066-reflecting-the-impact-of-recent-transactions
Bristol Myers Squibb Revises 2024 Adjusted...
04/25/2024 11:12:41

bristol-myers-squibb-says-it-is-executing-strategic-productivity-initiative-to-deliver-15b-in-cost-savings-the-majority-of-which-will-be-reinvested-to-fund-innovation-and-drive-growth
Bristol Myers Squibb Says It Is Executing ...
04/25/2024 11:08:54

bristol-myers-squibb-q1-2024-adj-eps-440-beats-444-estimate-sales-11865b-beat-11458b-estimate
Bristol-Myers Squibb Q1 2024 Adj EPS $(4.4...
04/25/2024 11:07:47

Bristol-Myers Squibb (NYSE:BMY) reported quarterly losses of $(4.40) per share which beat the analyst consensus estimate of $(4...

us-stocks-brace-for-negative-start-amid-tech-earnings-disappointments-caution-ahead-of-data-worst-of-this-two-week-decline-is-behind-us-says-analyst
US Stocks Brace For Negative Start Amid Te...
04/25/2024 10:17:18

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platfor...

bristol-myers-discloses-prelim-629-gaap--non-gaap-eps-impact-for-3-months-ended-march-31-related-to-acquired-iprd--licensing-income
Bristol-Myers Discloses Prelim. $6.29 GAAP...
04/24/2024 13:41:16

https://www.bms.com/assets/bms/us/en-us/pdf/investor-info/doc_financials/quarterly_reports/2024/Preliminary-Q1-2024-Acquired-IP...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION